IT8324430A0 - Attivita' antitosse e sedativa composti otticamente attivi ad centrale, procedimento per la loro preparazione e composizioni che licontengono. - Google Patents

Attivita' antitosse e sedativa composti otticamente attivi ad centrale, procedimento per la loro preparazione e composizioni che licontengono.

Info

Publication number
IT8324430A0
IT8324430A0 IT8324430A IT2443083A IT8324430A0 IT 8324430 A0 IT8324430 A0 IT 8324430A0 IT 8324430 A IT8324430 A IT 8324430A IT 2443083 A IT2443083 A IT 2443083A IT 8324430 A0 IT8324430 A0 IT 8324430A0
Authority
IT
Italy
Prior art keywords
anticough
centrally
compositions
procedure
contain
Prior art date
Application number
IT8324430A
Other languages
English (en)
Other versions
IT1203721B (it
Inventor
Massimiliano Borsa
Giancarlo Tonon
Salvatore Malandrino
Original Assignee
Dompe Farmaceutici Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Dompe Farmaceutici Spa filed Critical Dompe Farmaceutici Spa
Publication of IT8324430A0 publication Critical patent/IT8324430A0/it
Priority to IT24430/83A priority Critical patent/IT1203721B/it
Priority to AT84116334T priority patent/ATE50767T1/de
Priority to EP84116334A priority patent/EP0147847B1/en
Priority to JP59281944A priority patent/JPS60252474A/ja
Priority to DE8484116334T priority patent/DE3481510D1/de
Priority to US06/906,698 priority patent/US4699911A/en
Priority to US07/069,242 priority patent/US4764515A/en
Application granted granted Critical
Publication of IT1203721B publication Critical patent/IT1203721B/it
Priority to JP3007236A priority patent/JPH0662416B2/ja
Priority to JP3007235A priority patent/JPH0670027B2/ja

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/20—Free hydroxyl or mercaptan
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/18—Radicals substituted by singly bound oxygen or sulfur atoms
    • C07D317/22—Radicals substituted by singly bound oxygen or sulfur atoms etherified
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/32—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pulmonology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
IT24430/83A 1983-12-29 1983-12-29 Composti otticamente attivi ad attivita' antitosse e sedativa centrale,procedimento per la preparazione e composizioni che li contengono IT1203721B (it)

Priority Applications (9)

Application Number Priority Date Filing Date Title
IT24430/83A IT1203721B (it) 1983-12-29 1983-12-29 Composti otticamente attivi ad attivita' antitosse e sedativa centrale,procedimento per la preparazione e composizioni che li contengono
DE8484116334T DE3481510D1 (de) 1983-12-29 1984-12-27 Optisch aktive verbindungen mit antitassiver und zentral-sedativer wirkung, ein verfahren zu deren herstellung und diese enthaltende zusammensetzungen.
EP84116334A EP0147847B1 (en) 1983-12-29 1984-12-27 Optically active compounds with antitussive and central sedative activity, a process for the preparation thereof and compositions containing the same
JP59281944A JPS60252474A (ja) 1983-12-29 1984-12-27 （−）―３―（４―フェニル―１―ピペラジニル）―１，２―プロパンジオールを有効成分とする鎮咳剤
AT84116334T ATE50767T1 (de) 1983-12-29 1984-12-27 Optisch aktive verbindungen mit antitassiver und zentral-sedativer wirkung, ein verfahren zu deren herstellung und diese enthaltende zusammensetzungen.
US06/906,698 US4699911A (en) 1983-12-29 1986-09-11 Levo and dextro dropropizine having antitussive activity
US07/069,242 US4764515A (en) 1983-12-29 1987-07-02 Antitussive and central sedative composition of d-isomer of 3-(4-phenyl-1-piperazinyl)-1,2-propanediol
JP3007236A JPH0662416B2 (ja) 1983-12-29 1991-01-24 （＋）−３−（４−フェニル−１−ピペラジニル）−１，２−プロパンジオールを有効成分とする鎮静剤
JP3007235A JPH0670027B2 (ja) 1983-12-29 1991-01-24 ３−（４−フェニル−１−ピペラジニル）−１，２−プロパンジオールの光学対掌体の製法

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT24430/83A IT1203721B (it) 1983-12-29 1983-12-29 Composti otticamente attivi ad attivita' antitosse e sedativa centrale,procedimento per la preparazione e composizioni che li contengono

Publications (2)

Publication Number Publication Date
IT8324430A0 true IT8324430A0 (it) 1983-12-29
IT1203721B IT1203721B (it) 1989-02-23

Family

ID=11213495

Family Applications (1)

Application Number Title Priority Date Filing Date
IT24430/83A IT1203721B (it) 1983-12-29 1983-12-29 Composti otticamente attivi ad attivita' antitosse e sedativa centrale,procedimento per la preparazione e composizioni che li contengono

Country Status (6)

Country Link
US (2) US4699911A (it)
EP (1) EP0147847B1 (it)
JP (3) JPS60252474A (it)
AT (1) ATE50767T1 (it)
DE (1) DE3481510D1 (it)
IT (1) IT1203721B (it)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4837025A (en) * 1988-03-25 1989-06-06 Laboratoires D'hygiene Et De Dietetique Self-adhesive device for the percutaneous administration of an active ingredient
NL8801622A (nl) * 1988-06-25 1990-01-16 Stamicarbon Bereiding van enantiomeren van dropropizine.
IT1226570B (it) * 1988-08-01 1991-01-24 Bidachem Spa Procedimento di preparazione della levo- e destro-dropropizina
IT1231158B (it) * 1989-07-20 1991-11-19 Dompe Farmaceutici Spa Procedimento per la risoluzione ottica della dropropizina.
CA2112487C (en) * 1991-06-26 2003-04-15 James W. Young Method and compositions for treating emesis, nausea and other disorders using optically pure r(+) ondansetron
EP0661970A1 (en) * 1991-11-26 1995-07-12 Sepracor, Inc. Methods and compositions for treating hypertension, angina and other disorders using optically pure (-) amlodipine
IT1254452B (it) * 1992-02-14 1995-09-25 Dompe Farmaceutici Spa N-ossidi ed n,n'-diossidi di 3-(piperazin-1-il)-propan-1,2-dioli
IT1254993B (it) * 1992-06-24 1995-10-11 Procedimento per la preparazione degli enantiomeri della dropropizina
JP2002538102A (ja) 1999-03-01 2002-11-12 セプラコア インコーポレーテッド 光学的に純粋なｒ（＋）オンダンセトロンを使用する無呼吸および無呼吸障害の治療方法
IT1318650B1 (it) * 2000-07-28 2003-08-27 Dompe Spa 1,3-diossolani ad attivita' antitosse.
IT1318651B1 (it) * 2000-07-28 2003-08-27 Dompe Spa Sintesi di (+-)1,3-diossolani e loro risoluzione ottica.
CN102805746B (zh) * 2011-06-02 2016-02-10 湖南九典制药股份有限公司 一种作用于呼吸系统疾病的复方化学药及其制备工艺与应用
MX2017014725A (es) * 2017-11-16 2019-05-17 Productos Farm S A De C V Dropropizina en combinacion con ambroxol en la forma farmaceutica de jarabe y tabletas.

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE601394A (it) *
US3163649A (en) * 1964-12-29 Substituteb phenyl-piperazine
BE601794A (fr) * 1960-03-24 1961-09-25 Gabriel Co Mécanisme distributeur
GB938646A (en) * 1961-03-16 1963-10-02 Henri Morren New piperazine derivatives
NL275711A (it) * 1962-03-15
IT1210639B (it) * 1981-02-25 1989-09-14 Menarini Sas Prodotto: 3(4-fenil1piperazinio-1-il)-1,2-propandiolo 3(teofillin-7-il)-1propansolfonato,utilizzabile in terapia,e relativo procedimento di fabbricazione

Also Published As

Publication number Publication date
IT1203721B (it) 1989-02-23
ATE50767T1 (de) 1990-03-15
JPS60252474A (ja) 1985-12-13
JPH058688B2 (it) 1993-02-02
JPH0670027B2 (ja) 1994-09-07
DE3481510D1 (de) 1990-04-12
JPH05222019A (ja) 1993-08-31
JPH0662416B2 (ja) 1994-08-17
US4699911A (en) 1987-10-13
EP0147847B1 (en) 1990-03-07
US4764515A (en) 1988-08-16
JPH05221864A (ja) 1993-08-31
EP0147847A2 (en) 1985-07-10
EP0147847A3 (en) 1986-11-26

Similar Documents

Publication Publication Date Title
IT1225762B (it) Composti farmacologicamente attivi, procedimenti per la loro preparazione e composizioni che li contengono.
IT8324430A0 (it) Attivita' antitosse e sedativa composti otticamente attivi ad centrale, procedimento per la loro preparazione e composizioni che licontengono.
IT8547683A0 (it) Procedimento per la preparazione dicomposti 1,3-diossolan-4-metanolici otticamente attivi
IT8347605A0 (it) Uree e tiouree sostituite aventi attivita' antiaterosclerotica, procedimento per la loro preparazione e composizioni farmaceutiche che le contengono
DE3483385D1 (de) Physiologisch aktive zusammensetzungen.
IT1213173B (it) Composti ad attivita'antibatterica, procedimento per laloro preparazione e relative composizioni farmaceutiche.
IT8447964A1 (it) Complessi d'inclusione, loro preparazione e loro impiego come insetticidi.
IT8520691A0 (it) Rete per la selezione dinamica di eventi.
IT8320468A0 (it) Nuovi composti ad attivita'antiinfiammatoria, procedimento per la loro preparazione e composizioni farmaceutiche che licontengono.
IT8219486A0 (it) Nuovi composti ad attivita'antiinfiammatoria, procedimento per la loro preparazione e relative composizioni farmaceutiche.
ES546387A0 (es) Procedimiento pra la preparacion de 1,4-dihidropiridinas sustituidas,opticamente activas
IT8322045A0 (it) Per la loro preparazione e oligosaccaridi eterogenei relative composizioni complessabili ed alfa -idosani ad farmaceutiche. attivita' terapeutica, procedimento
IT1167746B (it) Nitroimidazoli ad attivita' tricomonacida, procedimento per la loro preparazione e relative composizioni farmaceutiche
IT8519903A0 (it) Farmaceutiche che li contengono. composti ad attivita'antiaggregante piastrinica, procedimento per la loro preparazione e composizioni
IT8321255A0 (it) Composti dotati di attivita'sedativa e tranquillante, procedimenti per prepararli e composizioni che li contengono.
NO163187C (no) Analogifremgangsm te for fremstilling av terapeutisk aktive 1,6-naftyridinderivater.
IT8321044A0 (it) Per la loro preparazione e relative composti idrossiminici e composizioni farmaceutiche. alcossiminici ad attivita'calcio-antagonista, procedimento
IT8222339A0 (it) Composti ad attivita'calcio-antagonista, metodo per laloro preparazione e composizioni farmaceutiche.
IT8319981A0 (it) Composti ad attivita' antivirale, procedimento per la loro preparazione e composizioni farmaceutiche cheli contengono.
IT8424156A0 (it) Composti ad attivita'antibatterica, procedimento per laloro preparazione e composizioni farmaceutiche che li contengono.
IT8519204A0 (it) Composti ad attivita' mucolitica e broncodilatatrice, procedimento per la loro preparazione e composizioni farmaceutiche che licontengono come principi attivi.
IT8421627A1 (it) Composizione farmaceutica contenente come ingrediente attivo 24,25-diidrossicolecalciferolo
IT8519251A0 (it) Composti ad attivita'antiiperlipidemica, loro preparazione e composizioni farmaceutiche che li contengono.
IT8320672A0 (it) Nuovi composti ad attivita'antineoplastica, procedimento per la loro preparazione e relative composizioni farmaceutiche.
IT1198378B (it) Composti idrossiminici e alcossiminici ad attivita' calcioanatagonista,procedimento per la loro preparazione e relative composizioni farmaceutiche